These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

560 related items for PubMed ID: 11125427

  • 1. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
    Shibata Y, Fukabori Y, Ito K, Suzuki K, Yamanaka H.
    J Urol; 2001 Jan; 165(1):289-93. PubMed ID: 11125427
    [Abstract] [Full Text] [Related]

  • 2. Relationship between prostatic atrophy and apoptosis in the canine spontaneous benign prostatic hyperplasia (BPH) following chlormadinone acetate (CMA).
    Murakoshi M, Ikeda R, Fukui N, Nakayama T.
    Tokai J Exp Clin Med; 2001 Jul; 26(2):71-5. PubMed ID: 11806444
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.
    Trachtenberg J, Hicks LL, Walsh PC.
    J Clin Invest; 1980 May; 65(5):1051-9. PubMed ID: 6154062
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of antiandrogen, chlormadinone acetate (CMA), in canine spontaneous benign prostatic hyperplasia (BPH).
    Murakoshi M, Ikada R, Tagawa M, Nakayama T.
    Tokai J Exp Clin Med; 2000 Apr; 25(1):11-4. PubMed ID: 11023050
    [Abstract] [Full Text] [Related]

  • 8. Immunolocalization of androgen receptor in canine prostatic hyperplasia--effect of antiandrogen.
    Murakoshi M, Ikeda R, Tagawa M, Nakayama T, Honma S, Mieda M.
    Tokai J Exp Clin Med; 1998 Nov; 23(5):209-12. PubMed ID: 10418722
    [Abstract] [Full Text] [Related]

  • 9. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
    Leav I, Schelling KH, Adams JY, Merk FB, Alroy J.
    Prostate; 2001 Aug 01; 48(3):210-24. PubMed ID: 11494337
    [Abstract] [Full Text] [Related]

  • 10. Androgen and prostatic stroma.
    Niu YJ, Ma TX, Zhang J, Xu Y, Han RF, Sun G.
    Asian J Androl; 2003 Mar 01; 5(1):19-26. PubMed ID: 12646998
    [Abstract] [Full Text] [Related]

  • 11. Immunohistochemical studies in canine prostatic hyperplasia--effect of antiandrogen.
    Murakoshi M, Ikeda R, Tagawa M, Nakayama T.
    Tokai J Exp Clin Med; 1999 Jun 01; 24(2):77-83. PubMed ID: 10641996
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Changes in serum prostate specific antigen and testosterone levels after chlormadinone acetate treatment in patients with benign prostatic hyperplasia : a prospective multicenter clinical study].
    Fujimoto K, Hirao Y, Ohashi Y, Shibata Y, Fuji K, Tsuji H, Shimizu N, Miyazawa K, Nagata M, Ohtani N, Furuya R, Boku E.
    Hinyokika Kiyo; 2011 Apr 01; 57(4):177-83. PubMed ID: 21646847
    [Abstract] [Full Text] [Related]

  • 14. Effects of a new steroidal aromatase inhibitor, TZA-2237, and/or chlormadinone acetate on hormone-induced and spontaneous canine benign prostatic hyperplasia.
    Ito K, Fukabori Y, Shibata Y, Suzuki K, Mieda M, Gotanda K, Honma S, Yamanaka H.
    Eur J Endocrinol; 2000 Oct 01; 143(4):543-54. PubMed ID: 11022202
    [Abstract] [Full Text] [Related]

  • 15. [Hormonal therapy for benign prostatic hyperplasia].
    Sakai H, Kanetake H.
    Nihon Rinsho; 2002 Dec 01; 60 Suppl 11():358-61. PubMed ID: 12599600
    [No Abstract] [Full Text] [Related]

  • 16. Finasteride targets prostate vascularity by inducing apoptosis and inhibiting cell adhesion of benign and malignant prostate cells.
    Sutton MT, Yingling M, Vyas A, Atiemo H, Borkowski A, Jacobs SC, Kyprianou N.
    Prostate; 2006 Aug 01; 66(11):1194-202. PubMed ID: 16652387
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of MENT on primary cell cultures from benign prostatic hyperplasia and prostate carcinoma.
    Mendoza P, Sánchez C, Contreras HR, Vergara J, Acevedo C, Cabezas J, Huidobro C, Noé G, Castellón EA.
    Int J Androl; 2009 Dec 01; 32(6):607-15. PubMed ID: 18637152
    [Abstract] [Full Text] [Related]

  • 19. New histopathological experimental model for benign prostatic hyperplasia: stromal hyperplasia in rats.
    Mori F, Oda N, Sakuragi M, Sakakibara F, Kiniwa M, Miyoshi K.
    J Urol; 2009 Feb 01; 181(2):890-8. PubMed ID: 19095262
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.